| Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease KE Murphy, AM Gysbers, SK Abbott, N Tayebi, WS Kim, E Sidransky, ... Brain 37 (3), 834-848, 2014 | 485 | 2014 |
| Eating and hypothalamus changes in behavioral‐variant frontotemporal dementia O Piguet, Å Petersén, B Yin Ka Lam, S Gabery, K Murphy, JR Hodges, ... Annals of neurology 69 (2), 312-319, 2011 | 221 | 2011 |
| Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease KE Murphy, AM Gysbers, SK Abbott, AS Spiro, A Furuta, A Cooper, ... Movement Disorders 30 (12), 1639-1647, 2015 | 166 | 2015 |
| Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease SK Abbott, H Li, SS Munoz, B Knoch, M Batterham, KE Murphy, ... Movement Disorders 29 (4), 518-526, 2014 | 133 | 2014 |
| Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy S Bohic, K Murphy, W Paulus, P Cloetens, M Salomé, J Susini, K Double Analytical chemistry 80 (24), 9557-9566, 2008 | 126 | 2008 |
| Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses S Gabery, K Murphy, K Schultz, CT Loy, E McCusker, D Kirik, G Halliday, ... Acta neuropathologica 120 (6), 777-788, 2010 | 117 | 2010 |
| No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism G Halliday, MT Herrero, K Murphy, H McCann, F Ros‐Bernal, C Barcia, ... Movement Disorders 24 (10), 1519-1523, 2009 | 106 | 2009 |
| ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies KE Murphy, L Cottle, AM Gysbers, AA Cooper, GM Halliday Acta neuropathologica communications 1 (1), 11, 2013 | 78 | 2013 |
| Glucocerebrosidase deficits in sporadic Parkinson disease KE Murphy, GM Halliday Autophagy 10 (7), 1350-1351, 2014 | 56 | 2014 |
| LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions Y Huang, YJC Song, K Murphy, JL Holton, T Lashley, T Revesz, WP Gai, ... Acta neuropathologica 116 (6), 639-646, 2008 | 46 | 2008 |
| Excessive dopamine neuron loss in progressive supranuclear palsy KE Murphy, T Karaconji, CD Hardman, GM Halliday Movement Disorders 23 (4), 607-610, 2008 | 35 | 2008 |
| Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T a-synuclein mutation Y Huang, F Chegini, G Chua, K Murphy, W Gai, GM Halliday Translational Neurodegeneration 1 (1), 2, 2012 | 27* | 2012 |
| Reproductive seasonality of three cold-temperate viviparous skinks from southeastern Australia K Murphy, S Hudson, G Shea Journal of Herpetology 40 (4), 454-465, 2006 | 23 | 2006 |
| Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease J Shehadeh, KL Double, KE Murphy, L Bobrovskaya, S Reyes, ... Neurobiology of disease 130, 104524, 2019 | 20 | 2019 |
| Pathology of Parkinson's disease G Halliday, K Murphy Blue Books of Neurology 34, 132-154, 2010 | 16 | 2010 |
| Pathology of Parkinson’s disease—an overview G Halliday, K Murphy Movement Disorders 4: Blue Books of Neurology Series, 132-154, 2010 | 16* | 2010 |
| Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy CL Kragh, AM Gysbers, E Rockenstein, K Murphy, GM Halliday, E Masliah, ... Neurobiology of disease 63, 171-183, 2014 | 13 | 2014 |
| Reply: Lysosomal dysfunction in Parkinson’s disease GM Halliday, KE Murphy Brain 138 (4), e340-e340, 2014 | 1 | 2014 |
| AUTOPHAGY-LYSOSOMAL PATHWAY DYSFUNCTION IN PARKINSON’S DISEASE KE Murphy | | 2013 |
